Soligenix to present at november 21st virtual investor summit microcap event

Princeton, nj / accesswire / november 15, 2024 / soligenix, inc. (nasdaq:sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it will be presenting at the upcoming q4 investor summit and will be available for 1-on-1 meetings throughout the day. event: q4 investor summit presentation time: 12:00pm - 12:30pm et location: https://www.webcaster4.com/webcast/page/3075/51675 the theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market.
SNGX Ratings Summary
SNGX Quant Ranking